Fragilidad y características clínicas en pacientes muy ancianos con falla cardiaca aguda

dc.contributor.advisorLópez Ramírez, Jorge Hernán
dc.contributor.authorCastañeda Camacho, Héctor Andrés
dc.date.accessioned2022-11-01T15:09:11Z
dc.date.available2022-11-01T15:09:11Z
dc.date.issued2022-10-05
dc.descriptionilustraciones, gráficasspa
dc.description.abstractFragilidad y características clínicas en pacientes muy ancianos con falla cardiaca aguda Introducción: La principal causa de hospitalización en ancianos es la falla cardiaca aguda, con alta morbimortalidad, principalmente cuando coexiste con la fragilidad, cuya prevalencia se encuentra hasta en un 70%. El objetivo del presente estudio fue determinar la prevalencia de este síndrome geriátrico en pacientes muy ancianos hospitalizados por falla cardiaca. Diseño: Estudio descriptivo de corte transversal. Métodos: Se incluyeron pacientes > 80 años hospitalizados con diagnóstico de falla cardiaca durante un periodo de 7 meses. Se tamizó la fragilidad con la escala clínica de fragilidad, considerando frágiles a los pacientes con una CFS > 5. Se evaluaron otros síndromes geriátricos y se realizó una descripción de las características clínicas y sociodemográficas de la población. Resultados: Se analizaron 123 pacientes, el promedio de edad fue 85.31 años ( DE 3.86). La prevalencia de fragilidad fue del 51.2% (IC95% 42% - 60%). Solo 22 % eran independientes en sus actividades básicas, 42.3 % cumplían con la definición de polifarmacia , 35 % tenía una alta carga de comorbilidad y 16.3 % cumplía con la definición de caedor recurrente. Las principales causas de descompensación identificadas fueron la exacerbación de EPOC y las infecciones como celulitis, sepsis abdominal y colecistitis aguda en un 22.8 %, seguido en un 17.07 % por el tromboembolismo pulmonar. Conclusiones: La prevalencia de fragilidad en pacientes muy ancianos con falla cardiaca aguda es elevada, para mitigar los efectos deletéreos de este síndrome geriátrico se deben realizar intervenciones para el control de la multimorbilidad, estado físico y cognitivo, además de ofrecer un manejo médico acorde a las guías y objetivos terapéuticos individualizados y con un seguimiento clínico estrecho. (Texto tomado de la fuente)spa
dc.description.abstractFrailty and clinical features in very elderly patients with acute heart failure Introduction: The main cause of hospitalization in the elderly is acute heart failure, with high morbidity and mortality, mainly when it coexists with frailty, whose prevalence is up to 70%. The objective of the present study was to determine the prevalence of this geriatric syndrome in very elderly patients hospitalized for heart failure. Design: Descriptive cross-sectional study. Methods: Patients > 80 years hospitalized with a diagnosis of heart failure for a period of 7 months were included. Frailty was screened using the clinical frailty scale, considering frail patients with a CFS > 5. Other geriatric syndromes were evaluated and a description of the clinical and sociodemographic characteristics of the population was made. Results: 123 patients were analyzed; the average age was 85.31 years (SD 3.86). The prevalence of frailty was 51.2% (95% CI 42% - 60%). Only 22% were independent in their basic activities, 42.3% met the definition of polypharmacy, 35% had a high burden of comorbidity, and 16.3% met the definition of recurrent faller. The main causes of decompensation identified were COPD exacerbation and infections such as cellulitis, abdominal sepsis, and acute cholecystitis in 22.8%, followed by pulmonary thromboembolism in 17.07%. Conclusions: The prevalence of frailty in very elderly patients with acute heart failure is high, to mitigate the deleterious effects of this geriatric syndrome, interventions should be carried out to control multimorbidity, physical and cognitive status, in addition to offering appropriate medical management to the guidelines and individualized therapeutic objectives, with a close clinical follow-up.eng
dc.description.degreelevelEspecialidades Médicasspa
dc.description.degreenameEspecialista en Geriatríaspa
dc.description.methodsMetodología Diseño del estudio: Estudio de corte transversal Población blanco Adultos mayores de 80 años o más, hospitalizados por falla cardiaca aguda en el Hospital Universitario San Rafael De Tunja, desde el 01 de Julio de 2021 hasta 31 de Enero de 2022. Tamaño de muestra: Muestra a conveniencia no probabilística Criterios de inclusión: Adultos mayores de 80 años o más, hospitalizados por falla cardiaca aguda. Criterios de exclusión: •Pacientes que no deseen firmar consentimiento informado para participar en el estudio •Historias clínicas con información inferior del 60% de los datos requeridos, o que no registren el tamizaje de fragilidad por medio de la escala clínica de fragilidad. •Pacientes duplicados en la base de datos Procedimientos y recolección de la información: Posterior a aprobación del comité de investigación y de ética del Hospital Universitario San Rafael De Tunja, los participantes fueron seleccionados a su ingreso a urgencias o sala general con diagnóstico de falla cardiaca descompensada y edad mayor o igual a 80 años. Previo diligenciamiento del consentimiento informado se estableció encuesta personal con el paciente y familiar para diligenciar contenido y variables correspondientes a la herramienta de recolección de datos, también aprobada por el comité de ética de la institución en mención . Para controlar la calidad de la información extraída, los coinvestigadores fueron entrenados en el diligenciamiento y conocimiento de las diferentes variables de la herramienta de recolección de datos, toda la Información complementaria fue obtenida a partir de la historia clínica sistematizada del Hospital Universitario San Rafael De Tunja accediendo al software Servinte®. La información de las variables obtenidas de la historia clínica y encuesta fue registrada por los investigadores en un formato de recolección físico y en el software Excel V2016. Para controlar la calidad de la información extraída y verificar errores, se realizó doble revisión de los datos diligenciados en el formato físico y el software Excel V2016. Se realizo revisión semanal entre el investigador principal y los demás investigadores del control de inconsistencias, para verificar la correcta digitación de los datos y adecuado diligenciamiento del instrumento de EXCEL.spa
dc.format.extentxvii, 83 páginasspa
dc.format.mimetypeapplication/pdfspa
dc.identifier.instnameUniversidad Nacional de Colombiaspa
dc.identifier.reponameRepositorio Institucional Universidad Nacional de Colombiaspa
dc.identifier.repourlhttps://repositorio.unal.edu.co/spa
dc.identifier.urihttps://repositorio.unal.edu.co/handle/unal/82595
dc.language.isospaspa
dc.publisherUniversidad Nacional De Colombiaspa
dc.publisher.branchUniversidad Nacional de Colombia - Sede Bogotáspa
dc.publisher.facultyFacultad de Medicinaspa
dc.publisher.programBogotá - Medicina - Especialidad en Geriatríaspa
dc.relation.indexedRedColspa
dc.relation.indexedLaReferenciaspa
dc.relation.references1. Metra M, Cotter G, El-Khorazaty J, Davison BA, Milo O, Carubelli V, et al. Acute heart failure in the elderly: Differences in clinical characteristics, outcomes, and prognostic factors in the Veritas study. J Card Fail [Internet]. 2015;21(3):179–88. Available from: http://dx.doi.org/10.1016/j.cardfail.2014.12.012spa
dc.relation.references2. Metra M, Teerlink JR. Heart failure. Lancet [Internet]. 2017;390(10106):1981–95. Available from: http://dx.doi.org/10.1016/S0140-6736(17)31071-1spa
dc.relation.references3. Calvachi Prieto P, Almánzar JS, Vega MP, Cárdenas YR, Gómez M, Celis E, et al. Clinical characteristics of acute heart failure patients according to left ventricular function. Rev Colomb Cardiol. 2018;25(1):7–12.spa
dc.relation.references4. Beltrami M, Milli M, Fumagalli C. Frailty, sarcopenia and cachexia in heart failure patients: Different clinical entities of the same painting. World J Cardiol. 2021;13(1):1–10.spa
dc.relation.references5. Arango DC, Peláez E. Envejecimiento poblacional en el siglo xxi: Oportunidades, retos y preocupaciones. Salud Uninorte. 2012;28(2):335–48.spa
dc.relation.references6. Díaz DM, Ochoa A, Corzo MA, Sanabria MC, Figueroa CL. Variables associated with frailty in a hospital population in Colombia. Geriatr Gerontol Aging. 2020;14(2):114–9.spa
dc.relation.references7. Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet. 2013;381(9868):752–62.spa
dc.relation.references8. Katsanos S, Bakosis G, Frogudaki A. Acute heart failure syndrome in the elderly. Contin Cardiol Educ. 2017;3(3):93–9.spa
dc.relation.references9. Kurmani S, Squire I. Acute Heart Failure: Definition, Classification and Epidemiology. Curr Heart Fail Rep. 2017;14(5):385–92.spa
dc.relation.references10. Farmakis D, Parissis J, Lekakis J, Filippatos G. Acute Heart Failure: Epidemiology, Risk Factors, and Prevention. Rev Española Cardiol (English Ed. 2015;68(3):245–8.spa
dc.relation.references11. Metra M, Cotter G, El-Khorazaty J, Davison BA, Milo O, Carubelli V, et al. Acute heart failure in the elderly: Differences in clinical characteristics, outcomes, and prognostic factors in the Veritas study. J Card Fail [Internet]. 2015;21(3):179–88. Available from: http://dx.doi.org/10.1016/j.cardfail.2014.12.012spa
dc.relation.references12. Gómez-Mesa JE, Saldarriaga CI, Echeverría LE, Luna P. Colombian heart failure registry (RECOLFACA): methodology and preliminary data. Rev Colomb Cardiol. 2021;28(3):217–30.spa
dc.relation.references13. Gustavo Piñar Sancho DCP. CUERPO EDITORIAL Heart failure in the elderly. Rev Medica Sinerg. 2020;5(9):10.spa
dc.relation.references14. Teixeira A, Arrigo M, Tolppanen H, Gayat E, Laribi S, Metra M, et al. Management of acute heart failure in elderly patients. Arch Cardiovasc Dis [Internet]. 2016;109(6–7):422–30. Available from: http://dx.doi.org/10.1016/j.acvd.2016.02.002spa
dc.relation.references15. Lindenfeld JA, O’Connor CM. Heart Failure in Women. JACC Hear Fail. 2019;7(3):274–5spa
dc.relation.references16. Chivite D, Formiga F, Pujol R. La insuficiencia cardíaca en el paciente anciano. Vol. 211, Revista Clinica Espanola. 2011. p. 26–35.spa
dc.relation.references17. Uchmanowicz I, Nessler J, Gobbens R, Gackowski A, Kurpas D, Straburzynska-Migaj E, et al. Coexisting Frailty With Heart Failure. Front Physiol. 2019;10(July).spa
dc.relation.references18. Llopis García G, Munk Sánchez S, García Briñón MÁ, Fernández Alonso C, González Del Castillo J, Martín-Sánchez FJ. El efecto de la fragilidad física en el pronóstico a largo plazo en los pacientes mayores con insuficiencia cardiaca aguda dados de alta desde un servicio de urgencias. Emergencias. 2019;31(6):413–6spa
dc.relation.references19. Martín-Sánchez FJ, Rodríguez-Adrada E, Mueller C, Vidán MT, Christ M, Frank Peacock W, et al. The Effect of Frailty on 30-day Mortality Risk in Older Patients With Acute Heart Failure Attended in the Emergency Department. Acad Emerg Med. 2017;24(3):298–307.spa
dc.relation.references20. Martín-Sánchez FJ, Rodríguez-Adrada E, Vidan MT, Llopis García G, González del Castillo J, Rizzi MA, et al. Impact of Frailty and Disability on 30-Day Mortality in Older Patients With Acute Heart Failure. Am J Cardiol. 2017;120(7):1151–7.spa
dc.relation.references21. Vidán AT, Sánchez E, Fernández-Avilés F, Serra-Rexach JA, Ortiz J, Bueno H. FRAIL-HF, a study to evaluate the clinical complexity of heart failure in nondependent older patients: Rationale, methods and baseline characteristics. Clin Cardiol. 2014;37(12):725–32.spa
dc.relation.references22. Pandey A, Kitzman D, Reeves G. Frailty Is Intertwined With Heart Failure: Mechanisms, Prevalence, Prognosis, Assessment, and Management. JACC Hear Fail [Internet]. 2019;7(12):1001–11. Available from: https://doi.org/10.1016/j.jchf.2019.10.005spa
dc.relation.references23. Costa D, Aladio M, Girado CA, Pérez de la Hoz R, Sara Berensztein C. Frailty is independently associated with 1-year mortality after hospitalization for acute heart failure. IJC Hear Vasc. 2018;21(2018):103–6.spa
dc.relation.references24. TANAKA S, KAMIYA K, HAMAZAKI N, MATSUZAWA R, NOZAKI K, MAEKAWA EMI, et al. Incremental Value of Objective Frailty Assessment to Predict Mortality in Elderly Patients Hospitalized for Heart Failure. J Card Fail [Internet]. 2018;24(11):723–32. Available from: https://doi.org/10.1016/j.cardfail.2018.06.006spa
dc.relation.references25. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: Evidence for a phenotype. Journals Gerontol - Ser A Biol Sci Med Sci. 2001;56(3):146–57.spa
dc.relation.references26. Gómez Montes JF, Curcio Borrero CL HGF en ancianos, Colombianos. COLOMBIANOS. Rev Médica Sánitas 2012;15(4)8-16. 2012;15(4):8–16.spa
dc.relation.references27. Samper-Ternent R, Reyes-Ortiz C, Ottenbacher KJ, Cano CA. Frailty and sarcopenia in Bogotá: results from the SABE Bogotá Study. Aging Clin Exp Res. 2017;29(2):265–72.spa
dc.relation.references28. Theou O, Brothers TD, Mitnitski A, Rockwood K. Operationalization of frailty using eight commonly used scales and comparison of their ability to predict all-cause mortality. J Am Geriatr Soc. 2013;61(9):1537–51.spa
dc.relation.references29. Afilalo J, Alexander KP, Mack MJ, Maurer MS, Green P, Allen LA, et al. Frailty assessment in the cardiovascular care of older adults. J Am Coll Cardiol. 2014;63(8):747–62.spa
dc.relation.references30. Martín-Sánchez FJ, Christ M, Miró Ò, Peacock WF, McMurray JJ, Bueno H, et al. Practical approach on frail older patients attended for acute heart failure. Int J Cardiol [Internet]. 2016;222(2016):62–71. Available from: http://dx.doi.org/10.1016/j.ijcard.2016.07.151spa
dc.relation.references31. Ramírez Ramírez JU, Cadena Sanabria MO, Ochoa ME. Aplicación de la Escala de fragilidad de Edmonton en población colombiana. Comparación con los criterios de Fried. Rev Esp Geriatr Gerontol. 2017;52(6):322–5.spa
dc.relation.references32. Tello-Rodríguez T, Varela-Pinedo L. Frailty in older adults: Detection, community-based intervention, and decision-making in the management of chronic illnesses. Rev Peru Med Exp Salud Publica. 2016;33(2):328–34.spa
dc.relation.references33. Sze S, Zhang J, Pellicori P, Morgan D, Hoye A, Clark AL. Prognostic value of simple frailty and malnutrition screening tools in patients with acute heart failure due to left ventricular systolic dysfunction. Clin Res Cardiol. 2017;106(7):533–41.spa
dc.relation.references34. Sze S, Pellicori P, Zhang J, Weston J, Clark AL. Identification of Frailty in Chronic Heart Failure. JACC Hear Fail. 2019;7(4):291–302.spa
dc.relation.references35. Katsanos S, Bistola V, Parissis JT. Acute Heart Failure Syndromes in the Elderly: The European Perspective. Heart Fail Clin. 2015;11(4):637–45.spa
dc.relation.references36. Zhou SL, Zhang J, Song TT, Li X, Wang HX. Diagnostic accuracy of natriuretic peptides for acute heart failure: A review. Eur Rev Med Pharmacol Sci. 2018;22(8):2415–20.spa
dc.relation.references37. Long B, Koyfman A, Gottlieb M. Diagnosis of Acute Heart Failure in the Emergency Department: An Evidence-Based Review. West J Emerg Med. 2019;20(6):875–84.spa
dc.relation.references38. Gök G, Karadağ M, Sinan ÜY, Zoghi M. A New Risk Score to Predict In-Hospital Mortality in Elderly Patients With Acute Heart Failure: On Behalf of the Journey HF-TR Study Investigators. Angiology. 2020;71(10):948–54.spa
dc.relation.references39. Jia Q, Wang YR, He P, Huang XL, Yan W, Mu Y, et al. Prediction model of in-hospital mortality in elderly patients with acute heart failure based on retrospective study. J Geriatr Cardiol. 2017;14(11):669–78.spa
dc.relation.references40. Duflos C, Troude P, Strainchamps D, Ségouin C, Logeart D, Mercier G. Hospitalization for acute heart failure: the in-hospital care pathway predicts one-year readmission. Sci Rep. 2020;10(1):1–8.spa
dc.relation.references41. Tersalvi G, Gasperetti A, Schiavone M, Dauw J, Gobbi C, Denora M, et al. Acute heart failure in elderly patients: A review of invasive and non-invasive management. J Geriatr Cardiol. 2021;18(7):560–76.spa
dc.relation.references42. Orso F, Pratesi A, Herbst A, Baroncini AC, Bacci F, Ciuti G, et al. Acute heart failure in the elderly: Setting related differences in clinical features and management. J Geriatr Cardiol. 2021;18(6):407–15.spa
dc.relation.references43. McIlvennan CK, Allen LA. Palliative care in patients with heart failure. BMJ. 2016;353:1–13.spa
dc.relation.references44. Araya PD, Galleguillos FA. Ageísmo Como Fenómeno Sociocultural Invisible Mayores. 2021;27(1):127–35.spa
dc.relation.references45. Martín-Sánchez FJ, Rodríguez-Adrada E, Llorens P, Formiga F. Mensajes clave para la atención inicial del anciano con insuficiencia cardiaca aguda. Rev Esp Geriatr Gerontol [Internet]. 2015;50(4):185–94. Available from: http://dx.doi.org/10.1016/j.regg.2015.02.005spa
dc.relation.references46. Ng KT, Yap JLL. Continuous infusion vs. intermittent bolus injection of furosemide in acute decompensated heart failure: systematic review and meta-analysis of randomised controlled trials. Anaesthesia. 2018;73(2):238–47.spa
dc.relation.references47. Albert Schweitzer Hospital, Lambarene, Gabon, and Institute of Tropical Medicine, University of Tübingen, Tübingen G. 需要引用的霍奇金第二肿瘤new England Journal. N Engl J Med. 2011;365:687–96.spa
dc.relation.references48. Frea S, Pidello S, Volpe A, Canavosio FG, Galluzzo A, Bovolo V, et al. Diuretic treatment in high-risk acute decompensation of advanced chronic heart failure—bolus intermittent vs. continuous infusion of furosemide: a randomized controlled trial. Clin Res Cardiol [Internet]. 2020;109(4):417–25. Available from: https://doi.org/10.1007/s00392-019-01521-yspa
dc.relation.references49. Herrero-Puente P, Jacob J, Martín-Sánchez FJ, Vázquez-Álvarez J, Martínez-Camblor P, Miró Ò, et al. Influence of Intravenous Nitrate Treatment on Early Mortality among Patients with Acute Heart Failure. NITRO-EAHFE Study. Rev Esp Cardiol. 2015;68(11):959–67.spa
dc.relation.references50. Llorens P, Miró Ò, Martín Sánchez FJ, Herrero Puente P, Jacob Rodríguez J, Gil V, et al. Manejo de la insuficiencia cardiaca aguda en los servicios de urgencias, emergencias y unidades adscritas. Documento de consenso del Grupo de Insuficiencia Cardiaca Aguda de la Sociedad Española de Medicina de Urgencias y Emergencias (ICA-SEMES). Emergencias. 2011;23(2):119–39.spa
dc.relation.references51. Holt DB, Pang PS. Vasodilator Therapies in the Treatment of Acute Heart Failure. Curr Heart Fail Rep. 2019;16(1):32–7.spa
dc.relation.references52. Kamran H, Tang WHW. Medical management of acute heart failure. Fac Rev. 2021 Dec 6;10:82. doi: 10.12703/r/10-82. PMID: 35028647; PMCID: PMC872564spa
dc.relation.references53. Mebazaa A, Tolppanen H, Mueller C, Lassus J, DiSomma S, Baksyte G, et al. Acute heart failure and cardiogenic shock: a multidisciplinary practical guidance. Intensive Care Med. 2016;42(2):147–63.spa
dc.relation.references54. Butler J, Anstrom KJ, Felker GM, Givertz MM, Kalogeropoulos AP, Konstam MA, et al. Efficacy and safety of spironolactone in acute heart failure: The ATHENA-HF randomized clinical trial. JAMA Cardiol. 2017;2(9):950–8.spa
dc.relation.references55. Tomasoni D, Adamo M, Anker MS, von Haehling S, Coats AJS, Metra M. Heart failure in the last year: progress and perspective. ESC Hear Fail. 2020;7(6):3505–30.spa
dc.relation.references56. Mohyeldin M, Tavares LB, Boorenie M, Abureesh D, Ejaz S, Durrani L, et al. Efficacy of Sacubitril/Valsartan in the Setting of Acute Heart Failure: A Systematic Review. Cureus. 2021;13(10).spa
dc.relation.references57. Velazquez EJ, Morrow DA, DeVore AD, Duffy CI, Ambrosy AP, McCague K, et al. Angiotensin–Neprilysin Inhibition in Acute Decompensated Heart Failure. N Engl J Med. 2019;380(6):539–48.spa
dc.relation.references58. Wachter R, Senni M, Belohlavek J, Straburzynska-Migaj E, Witte KK, Kobalava Z, et al. Initiation of sacubitril/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised TRANSITION study. Eur J Heart Fail. 2019;21(8):998–1007.spa
dc.relation.references59. Pablo A. Olavegogeascoechea. De la evidencia a la práctica en la insuficiencia cardíaca. Rev Argentina Med. 2017;5(2):132–3.spa
dc.relation.references60. Solomon SD, McMurray JJV, Anand IS, Ge J, Lam CSP, Maggioni AP, et al. Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction. N Engl J Med. 2019;381(17):1609–20.spa
dc.relation.references61. Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Vol. 145, Circulation. 2022. 895–1032 p.spa
dc.relation.references62. Damman K, Beusekamp JC, Boorsma EM, Swart HP, Smilde TDJ, Elvan A, et al. Randomized, double-blind, placebo-controlled, multicentre pilot study on the effects of empagliflozin on clinical outcomes in patients with acute decompensated heart failure (EMPA-RESPONSE-AHF). Eur J Heart Fail. 2020;22(4):713–22.spa
dc.relation.references63. Bhatt DL, Szarek M, Steg PG, Cannon CP, Leiter LA, McGuire DK, et al. Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure. N Engl J Med. 2021;384(2):117–28.spa
dc.relation.references64. Pandey A, Kitzman D, Whellan DJ, Duncan PW, Mentz RJ, Pastva AM, et al. Frailty Among Older Decompensated Heart Failure Patients: Prevalence, Association With Patient-Centered Outcomes, and Efficient Detection Methods. JACC Hear Fail. 2019;7(12):1079–88.spa
dc.relation.references65. Lemus Barrios GA, Morales Benavidez DC, López Salazar AM, Henao V, González-Robledo G. Assessment of frailty in cardiovascular disease: A necessary challenge. Rev Colomb Cardiol [Internet]. 2020;27(4):283–93. Available from: https://doi.org/10.1016/j.rccar.2019.12.015spa
dc.relation.references66. Moorhouse P, Rockwood K. Frailty and its quantitative clinical evaluation. J R Coll Physicians Edinb. 2013;42(4):333–40.spa
dc.relation.references67. Theou O, Campbell S, Malone ML, Rockwood K. Older Adults in the Emergency Department with Frailty. Clin Geriatr Med. 2018;34(3):369–86.spa
dc.relation.references68. Matsue Y, Kamiya K, Saito H, Saito K, Ogasahara Y, Maekawa E, et al. Prevalence and prognostic impact of the coexistence of multiple frailty domains in elderly patients with heart failure: the FRAGILE-HF cohort study. Eur J Heart Fail. 2020;22(11):2112–9.spa
dc.relation.references69. Díaz-Toro F, Nazzal Nazal C, Verdejo H, Rossel V, Castro P, Larrea R, et al. Factores asociados a fragilidad en pacientes hospitalizados con insuficiencia cardiaca descompensada. Rev Med Chil. 2017;145(2):164–71.spa
dc.relation.references70. Sloane PD, Cesari M. Research on Frailty: Continued Progress, Continued Challenges. J Am Med Dir Assoc [Internet]. 2018;19(4):279–81. Available from: https://doi.org/10.1016/j.jamda.2018.01.003spa
dc.relation.references71. Liang YD, Zhang YN, Li YM, Chen YH, Xu JY, Liu M, et al. Identification of frailty and its risk factors in elderly hospitalized patients from different wards: A cross-sectional study in China. Clin Interv Aging. 2019;14:2249–59.spa
dc.relation.references72. O’Caoimh R, Costello M, Small C, Spooner L, Flannery A, O’Reilly L, et al. Comparison of frailty screening instruments in the emergency department. Int J Environ Res Public Health. 2019;16(19):1–13.spa
dc.relation.references73. Wallis SJ, Wall J, Biram RWS, Romero-Ortuno R. Association of the clinical frailty scale with hospital outcomes. Qjm. 2015;108(12):943–9.spa
dc.relation.references74. Kanenawa K, Isotani A, Yamaji K, Nakamura M, Tanaka Y, Hirose-Inui K, et al. The impact of frailty according to Clinical Frailty Scale on clinical outcome in patients with heart failure. ESC Hear Fail. 2021;8(2):1552–61.spa
dc.relation.references75. Strandberg TE, Nieminen T. Future Perspectives on the Role of Frailty in Cardiovascular Diseases. Vol. 1216, Advances in Experimental Medicine and Biology. 2020. 149–152 p.spa
dc.relation.references76. Yaku H, Kato T, Morimoto T, Inuzuka Y, Tamaki Y, Ozasa N, et al. Risk factors and clinical outcomes of functional decline during hospitalisation in very old patients with acute decompensated heart failure: An observational study. BMJ Open. 2020;10(2).spa
dc.relation.references77. Szanton SL, Seplaki CL, Thorpe RJ, Allen JK, Fried LP. Socioeconomic status is associated with frailty: The Women’s Health and Aging Studies. J Epidemiol Community Health. 2010;64(1):63–7.spa
dc.relation.references78. Wang J, Hulme C. Frailty and socioeconomic status: A systematic review. J Public health Res. 2021;10(3):553–60.spa
dc.relation.references79. Aimo A, Barison A, Mammini C, Emdin M. The Barthel Index in elderly acute heart failure patients. Frailty matters. Int J Cardiol [Internet]. 2018;254:240–1. Available from: https://doi.org/10.1016/j.ijcard.2017.11.010spa
dc.relation.references80. Chivite D, Formiga F, Corbella X, Conde-Martel A, Aramburu Ó, Carrera M, et al. Basal functional status predicts one-year mortality after a heart failure hospitalization in elderly patients — The RICA prospective study. Int J Cardiol [Internet]. 2018;254:182–8. Available from: https://doi.org/10.1016/j.ijcard.2017.10.104spa
dc.relation.references81. Formiga F, Chivite D, Conde A, Ruiz-Laiglesia F, Franco ÁG, Bocanegra CP, et al. Basal functional status predicts three-month mortality after a heart failure hospitalization in elderly patients - The prospective RICA study. Int J Cardiol [Internet]. 2014;172(1):127–31.spa
dc.relation.references82. Claret PG, Stiell IG, Yan JW, Clement CM, Rowe BH, Calder LA, et al. Characteristics and outcomes for acute heart failure in elderly patients presenting to the ED. Am J Emerg Med [Internet]. 2016;34(11):2159–66.spa
dc.relation.references83. Wu Y, Zhu W, He X, Xue R, Liang W, Wei F, et al. Influence of polypharmacy on patients with heart failure with preserved ejection fraction: A retrospective analysis on adverse outcomes in the TOPCAT trial. Br J Gen Pract. 2021;71(702):E62–70.spa
dc.relation.references84. Beezer J, Al Hatrushi M, Husband A, Kurdi A, Forsyth P. Polypharmacy definition and prevalence in heart failure: a systematic review. Heart Fail Rev [Internet]. 2022;27(2):465–92.spa
dc.relation.references85. Unlu O, Levitan EB, Reshetnyak E, Kneifati-Hayek J, Diaz I, Archambault A, et al. Polypharmacy in Older Adults Hospitalized for Heart Failure. Circ Hear Fail. 2020;13(11):E006977.spa
dc.relation.references86. Mastromarino V, Casenghi M, Testa M, Gabriele E, Coluccia R, Rubattu S, et al. Polypharmacy in heart failure patients. Curr Heart Fail Rep. 2014;11(2):212–9.spa
dc.relation.references87. Reed BN, Rodgers JE, Sueta CA. Polypharmacy in Heart Failure. Drugs to Use and Avoid. Heart Fail Clin [Internet]. 2014;10(4):577–90.spa
dc.relation.references88. Pazan F, Wehling M. Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequences. Eur Geriatr Med [Internet]. 2021;12(3):443–52.spa
dc.relation.references89. Rao VN, Fudim M, Savarese G, Butler J. Polypharmacy in Heart Failure with Reduced Ejection Fraction: Progress, Not Problem. Am J Med [Internet]. 2021;134(9):1068–70.spa
dc.relation.references90. Veenis JF, Brunner-La Rocca HP, Linssen GCM, Geerlings PR, Van Gent MWF, Aksoy I, et al. Age differences in contemporary treatment of patients with chronic heart failure and reduced ejection fraction. Eur J Prev Cardiol. 2019;26(13):1399–407.spa
dc.relation.references91. Milinković I, Polovina M, Coats AJ, Rosano GM, Seferović PM. Medical Treatment of Heart Failure with Reduced Ejection Fraction in the Elderly. Card Fail Rev. 2022;8.spa
dc.relation.references92. Younis A, Mulla W, Goldkorn R, Klempfner R, Peled Y, Arad M, et al. Differences in Mortality of New-Onset (De-Novo) Acute Heart Failure Versus Acute Decompensated Chronic Heart Failure. Am J Cardiol [Internet]. 2019;124(4):554–9.spa
dc.relation.references93. Formiga F, Moreno-Gonzalez R, Chivite D, Franco J, Montero A, Corbella X. High comorbidity, measured by the Charlson Comorbidity Index, associates with higher 1-year mortality risks in elderly patients experiencing a first acute heart failure hospitalization. Aging Clin Exp Res [Internet]. 2018;30(8):927–33.spa
dc.relation.references94. Franco Jonathan , Formiga Francesc , Chivite David,Corbella Javier, Robert Jordi, Vidaller Antonio, Charte Angel. Insuficiencia cardiaca aguda en el anciano:Características clínicas y mortalidad según la fracción de eyección ventricular izquierda.Rev Colomb Cardiol. 2017;24(3):250-254spa
dc.relation.references95. Kim V, Aaron SD. What is a COPD exacerbation? Current definitions, pitfalls, challenges and opportunities for improvement. Eur Respir J [Internet]. 2018;52(5). Available from: http://dx.doi.org/10.1183/13993003.01261-2018spa
dc.relation.references96. Jacob J, Tost J, Miró Ò, Herrero P, Martín-Sánchez FJ, Llorens P. Impact of chronic obstructive pulmonary disease on clinical course after an episode of acute heart failure. EAHFE–COPD study. Int J Cardiol [Internet]. 2017;227:450–6.spa
dc.relation.references97. Van Den Berge JC, Van Vark LC, Postmus D, Utens EMWJ, Hillege HL, Boersma E, et al. Determinants of quality of life in acute heart failure patients with and without comorbidities: a prospective, observational study. Eur J Cardiovasc Nurs. 2022;21(3):205–12.spa
dc.relation.references98. Gulea C, Zakeri R, Kallis C, Quint JK. Impact of COPD and asthma on in- ­ hospital mortality and management of patients with heart failure in England and Wales : an observational analysis. 2022;1–10.spa
dc.relation.references99. Sung SH, Wang TJ, Cheng HM, Yu WC, Guo CY, Chiang CE, et al. Clinical Characteristics and Outcomes in the Very Elderly Patients Hospitalized for Acute Heart Failure: Importance of Pharmacologic Guideline Adherence. Sci Rep [Internet]. 2018;8(1):4–11.spa
dc.relation.references100. Arrigo M, Jessup M, Mullens W, Reza N, Shah AM, Sliwa K, et al. Acute heart failure. Nat Rev Dis Prim [Internet]. 2020;6(1). Available from: http://dx.doi.org/10.1038/s41572-020-0151-7spa
dc.relation.references101. Alvarado CS, Avila RY-, Marron-veria E, Málaga-zenteno J, Adamkiewicz T V, Hematología S De, et al. Avances en el diagnóstico y tratamiento de deficiencia de hierro y anemia ferropenica Advances in the diagnosis and treatment of iron deficiency and iron deficiency anemia. 2022;83(1):65–9.spa
dc.relation.references102. Chopra VK, Anker SD. Anaemia, iron deficiency and heart failure in 2020: facts and numbers. ESC Hear Fail. 2020;7(5):2007–11.spa
dc.relation.references103. Loncar G, Obradovic D, Thiele H, von Haehling S, Lainscak M. Iron deficiency in heart failure. ESC Hear Fail. 2021;8(4):2368–79.spa
dc.relation.references104. Rizzo C, Carbonara R, Ruggieri R, Passantino A, Scrutinio D. Iron Deficiency: A New Target for Patients With Heart Failure. Front Cardiovasc Med. 2021;8(August).spa
dc.relation.references105. Cunha GJL, Rocha BML, Menezes Falcão L. Iron deficiency in chronic and acute heart failure: A contemporary review on intertwined conditions. Eur J Intern Med. 2018;52(April):1–7.spa
dc.relation.references106. Tee SL, Sindone A, Roger S, Atherton J, Amerena J, D’Emden M, et al. Hyponatraemia in heart failure. Intern Med J. 2020;50(6):659–66.spa
dc.relation.references107. Matsue Y, Yoshioka K, Suzuki M, Torii S, Yamaguchi S, Fukamizu S, et al. Prognostic importance of sodium level trajectory in acute heart failure. Heart Vessels. 2017;32(12):1498–505.spa
dc.relation.references108. Liamis G, Filippatos TD, Elisaf MS. Thiazide-associated hyponatremia in the elderly: What the clinician needs to know. J Geriatr Cardiol. 2016;13(2):175–82.spa
dc.relation.references109. Carubelli V, Metra M, Lombardi C, Bettari L, Bugatti S, Lazzarini V, et al. Renal dysfunction in acute heart failure: Epidemiology, mechanisms and assessment. Heart Fail Rev. 2012;17(2):271–82.spa
dc.relation.references110. McCullough PA, Jefferies JL. Novel markers and therapies for patients with acute heart failure and renal dysfunction. Am J Med [Internet]. 2015;128(3):312.e1-312.e22. Available from: http://dx.doi.org/10.1016/j.amjmed.2014.10.035spa
dc.relation.references111. Matsue Y, Van Der Meer P, Damman K, Metra M, O’Connor CM, Ponikowski P, et al. Blood urea nitrogen-to-creatinine ratio in the general population and in patients with acute heart failure. Heart. 2017;103(6):407–13.spa
dc.relation.references112. Pourafkari L, Tajlil A, Nader ND. Biomarkers in diagnosing and treatment of acute heart failure. Biomark Med. 2019;13(14):1235–49.spa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.licenseAtribución-NoComercial-SinDerivadas 4.0 Internacionalspa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/spa
dc.subject.ddc610 - Medicina y saludspa
dc.subject.lembHeart - diseaseseng
dc.subject.lembEnfermedades cardiacasspa
dc.subject.lembEnfermedades de los ancianosspa
dc.subject.lembAged - Diseaseseng
dc.subject.proposalAncianospa
dc.subject.proposalFalla cardiaca agudaspa
dc.subject.proposalFragilidadspa
dc.titleFragilidad y características clínicas en pacientes muy ancianos con falla cardiaca agudaspa
dc.title.translatedFrailty and clinical features in very elderly patients with acute heart failureeng
dc.typeTrabajo de grado - Especialidad Médicaspa
dc.type.coarhttp://purl.org/coar/resource_type/c_bdccspa
dc.type.coarversionhttp://purl.org/coar/version/c_ab4af688f83e57aaspa
dc.type.contentTextspa
dc.type.driverinfo:eu-repo/semantics/masterThesisspa
dc.type.redcolhttp://purl.org/redcol/resource_type/TMspa
dc.type.versioninfo:eu-repo/semantics/acceptedVersionspa
dcterms.audience.professionaldevelopmentBibliotecariosspa
dcterms.audience.professionaldevelopmentEstudiantesspa
dcterms.audience.professionaldevelopmentInvestigadoresspa
oaire.accessrightshttp://purl.org/coar/access_right/c_abf2spa
oaire.awardtitleFragilidad y características clínicas en pacientes muy ancianos con falla cardiaca agudaspa

Archivos

Bloque original

Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
1052385171.2022.pdf
Tamaño:
1.09 MB
Formato:
Adobe Portable Document Format
Descripción:
Tesis de Especialidad Médica en Geriatría

Bloque de licencias

Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
license.txt
Tamaño:
5.74 KB
Formato:
Item-specific license agreed upon to submission
Descripción: